The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2
Open Access
- 23 March 2021
- journal article
- letter
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 6 (1) , 1-3
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (81822027, 81902108, 81630090)
This publication has 9 references indexed in Scilit:
- Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacyScience, 2020
- Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2Signal Transduction and Targeted Therapy, 2020
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell, 2020
- Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 InfectionCell Reports, 2020
- Identification of Human Single-Domain Antibodies against SARS-CoV-2Cell Host & Microbe, 2020
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyNature, 2020
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibodyEmerging Microbes & Infections, 2020
- Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015Emerging Infectious Diseases, 2019
- Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and FitnessJournal of Virology, 2014